Retuerto-Guerrero, M, Morales, CM, Santos, CS, Herránz, LS, Juan, J, Castellvi, I, Alvarez, ED. COMPARATIVE ANALYSIS OF PROGRESSIVE PULMONARY FIBROSIS CRITERIA IN SYSTEMIC SCLEROSIS PATIENTS. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1597. PMID:. IF:20.600(Q1/1D).

Valera-Ribera, C, Alegre-Sancho, JJ, Castellvi, I, Ibanez, M, Garcia, FJN. DISTINCTIVE CLINICAL TRAITS OF ANTICENTROMERE ANTIBODY-POSITIVE SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A MULTICENTER RETROSPECTIVE STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B3437. PMID:. IF:20.600(Q1/1D).

Paños, HB, Saborit, MC, Lasanta, MAL, Lizarzaburu, MS, Ruiz-Esquide, V, Vilaseca, DR, Nack, A, Perez-Garcia, C, Bernardez, J, Guillen, AG, Aguilar, JR, Cuervo, A, Roc, MV, Gomez, CG, Mínguez, S, Novell, RM, Estrada, P, Martinez-Morillo, M, Grau, CP, Busquets-Perez, N, Park, HS, Gómez-Puerta, JA, Pérez, SH, Palau, NM, Sanmarti, R, Mateo, L, Diaz-Torne, C, Corominas, H, Alarcon, GS. UNDERSTANDING THE IMPACT OF EMA/PRAC SAFETY RECOMMENDATIONS ON THE REAL-WORLD USE OF JAK INHIBITORS IN RA. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B3117. PMID:. IF:20.600(Q1/1D).

Avilés, A, Plaza, Z, Sánchez-Alonso, F, Castañeda, S, Fernández-Gutiérrez, B, Diaz-Torne, C, Pilar, FU, González, OM, Gallego, JMS, Giner, E, Cid, AR, Gómez, AP, Nievas, GS, García, J, Juanatey, CG, Llorca, J, González-Gay, MA, Andrés, M. PROGNOSTIC VALUE OF HYPERURICEMIA IN DEVELOPING CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC INFLAMMATORY ARTHRITIS: A 10-YEAR PROSPECTIVE STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.A1239. PMID:. IF:20.600(Q1/1D).

López-Gutiérrez, F, Loricera, J, Tofade, T, Prieto-Peña, D, Romero-Yuste, S, De Miguel, E, Riveros-Frutos, A, Nuñez, DF, Ferraz-Amaro, I, Castañeda, S, Labrador-Sánchez, E, Maiz, O, Garcia, FJN, Galindez-Agirregoikoa, E, González, I, Urruticoechea-Arana, A, Calvo, AR, Moya, P, Unizony, S, Blanco, R. EFFECTIVENESS AND SAFETY OF JANUS KINASE INHIBITORS IN GIANT CELL ARTERITIS. REAL-WORLD CLINICAL PRACTICE STUDY AND LITERATURE REVIEW. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B2775. PMID:. IF:20.600(Q1/1D).

Sanmarti, R, Perez-Garcia, C, de-Toro-Santos, FJ, Alarcon, GS, Escudero-Contreras, A, Cuervo, A, Graell, E, Reina, D, Binstock, EK, Corominas, H, Urionaguena-Onaindia, I, Lasanta, MAL, Alejandro, O, Gomez, MS, Frade-Sosa, B, Novell, RM, Polino, L, Ostiz, JAM, Oreiro, N, Blanco, FJ, Nadales, IP, Ortega-Castro, R, Busquets-Pérez, N, Gómez-Centeno, A, Camacho, O, Cros, JRR, Arciniegas, AMM, Llorente, JFG, Paños, HB, Prior-Español, A, Quiñones, SC, Cruceta, A, Bonfill, E, Gómez, GD, Fàbregas, AR, Maestre, LT, Gomara, MJ, Haro, I. EFFECTS OF ABATACEPT VERSUS HYDROXYCHLOROQUINE ON THE PROGRESSION TO RHEUMATOID ARTHRITIS IN PALINDROMIC RHEUMATISM: ATWO-YEAR MULTICENTER RANDOMIZED CLINICAL TRIAL. THE PALABA STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B938. PMID:. IF:20.600(Q1/1D).

López-Gutiérrez, F, Loricera, J, Calabuig, PM, Gil, JJF, González-Mazario, R, Hormigos, C, Freites, D, Laguna, MR, Moya, P, Gómez, ML, Corominas, H, Silva-Díaz, M, Arribas, GG, García-Aparicio, A, Font, J, Casafont-Solé, I, Castaneda, E, Argumánez, CM, Zas, R, Molina-Collada, J, Montero, SR, Melero-González, RB, Galindez-Agirregoikoa, E, Hernández, A, Pantoja, L, Abascal, IB, Jovani, V, Valls-Pascual, E, Mena-Vázquez, N, Gallego, A, Cabaleiro-Raña, N, González, RV, Andrés, M, Castañeda, S. CLINICAL PRESENTATION OF IGG4-RELATED DISEASE. MULTICENTER STUDY AND LITERATURE REVIEW. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B3669. PMID:. IF:20.600(Q1/1D).

De Miguel, E, Dominguez-Alvaro, M, Hernández-Rodríguez, I, Silva-Díaz, M, Otano, JMB, Moya, P, Cabañas, MT, Angeles, VAN, Calvet, J, Casafont-Solé, I, Ivorra, JAR, Labrada-Arrabal, S, Vasques-Rocha, M, Iñiguez, CL, Dorta, AG, Fernández, CC, Villar, MA, Mas, AJ, Prado, FJ, Blanco, R. ACR/EULAR 2022 CLASSIFICATION CRITERIA COMPARED TO THE ACR 1990 CLASSIFICATION CRITERIA IN THE ARTESER REGISTRY OF GIANT CELL ARTERITIS. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B849. PMID:. IF:20.600(Q1/1D).